These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4891890)

  • 1. Prediction of psychopharmacologic effect in man: development and validation of a computerized diagnostic decision tree.
    Honigfeld G; Klein DF; Feldman S
    Comput Biomed Res; 1969 Jun; 2(4):350-61. PubMed ID: 4891890
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of drug effect by diagnostic decision tree.
    Klein DF; Honigfeld G; Feldman S
    Dis Nerv Syst; 1968 May; 29(5):Suppl:159-87. PubMed ID: 4876986
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of psychiatric diagnosis in prediction of clinical drug effects.
    Klein DF
    Arch Gen Psychiatry; 1967 Jan; 16(1):118-26. PubMed ID: 5333776
    [No Abstract]   [Full Text] [Related]  

  • 4. The reliability of a decision tree technique applied to psychiatric diagnosis.
    Feldman S; Klein DF; Honigfeld G
    Biometrics; 1972 Sep; 28(3):831-40. PubMed ID: 5073255
    [No Abstract]   [Full Text] [Related]  

  • 5. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients.
    Michaux MH; Kurland AA; Agallianos DD
    Curr Ther Res Clin Exp; 1966 Mar; 8(3):Suppl:117-52. PubMed ID: 4956162
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidepressants in black and white inpatients. Differential response to a controlled trial of chlorpromazine and imipramine.
    Raskin A; Crook TH
    Arch Gen Psychiatry; 1975 May; 32(5):643-9. PubMed ID: 1092283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative trial of imipramine and chlorpromazine in depressed patients.
    Paykel ES; Price JS; Gillan RU; Palmai G; Chesser ES
    Br J Psychiatry; 1968 Oct; 114(515):1281-7. PubMed ID: 4880979
    [No Abstract]   [Full Text] [Related]  

  • 8. A guide for drug use in depressive disorders.
    Raskin A
    Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190
    [No Abstract]   [Full Text] [Related]  

  • 9. Chlorpromazine-placebo, chlorpromazine-chlordiazepoxide, and chlorpromazine-imipramine treatment of acutely ill patients: symptoms and symptom patterns.
    Michaux MH; Kurland AA; Vander Zwaag L
    Psychopharmacol Bull; 1967 Dec; 4(3):22-8. PubMed ID: 5615553
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders.
    Fink M; Klein DF; Kramer JC
    Psychopharmacologia; 1965 Jan; 7(1):27-36. PubMed ID: 5318921
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined pharmacotherapy and psychotherapy.
    Uhlenhuth EH; Lipman RS; Covi L
    J Nerv Ment Dis; 1969 Jan; 148(1):52-64. PubMed ID: 4388798
    [No Abstract]   [Full Text] [Related]  

  • 12. The NIMH collaborative depression studies--a progress report.
    Raskin A
    Psychopharmacol Bull; 1972 Jul; 8(3):55-9. PubMed ID: 4559524
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders.
    Klein DF
    Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:146-9. PubMed ID: 5328014
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients.
    Douglas KW; Hindley JP
    J Clin Pharmacol J New Drugs; 1969; 9(3):176-82. PubMed ID: 4892453
    [No Abstract]   [Full Text] [Related]  

  • 15. Techniques used to assess the efficacy of psychotropic drugs: a critical review.
    Newmark CS
    Psychol Rep; 1971 Jun; 28(3):715-23. PubMed ID: 4934574
    [No Abstract]   [Full Text] [Related]  

  • 16. Pragmatic considerations of current models in the predictors of psychiatric drug effects.
    Sheppard C; Merlis S
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:11-4. PubMed ID: 4886989
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.
    Raskin A; Schulterbrandt JG; Reatig N; McKeon JJ
    Arch Gen Psychiatry; 1970 Aug; 23(2):164-73. PubMed ID: 4913665
    [No Abstract]   [Full Text] [Related]  

  • 18. Do psyhiatric out-patients take their drugs?
    Willcox DR; Gillan R; Hare EH
    Br Med J; 1965 Oct; 2(5465):790-2. PubMed ID: 5825418
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment: side effects and clinical laboratory findings.
    Kurland AA; Bethon GD; Michaux MH; Agallianos DD
    J New Drugs; 1966; 6(2):80-95. PubMed ID: 5331284
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia.
    Becker RE
    Am J Psychiatry; 1983 Feb; 140(2):208-11. PubMed ID: 6336916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.